Clinical characteristics at the time of diagnosis of incomplete and complete AVB
. | Incomplete (N = 122) . | Complete (N = 263) . | P-value . | |
---|---|---|---|---|
Sex | Women | 57 (46.7%) | 136 (51.7%) | 0.36 |
Men | 65 (53.3%) | 127 (48.3%) | ||
Age at diagnosis | Min–max | [0.0; 17.0] | [0.0; 18.0] | 0.0109 |
Mean ± SD | 3.6 ± 3.9 | 4.7 ± 4.7 | ||
Median [Q1; Q3] | 2.0 [1.0; 6.0] | 3.0 [0.0; 7.0] | ||
Congenital | N = 34 | 13 (10.7%) | 21 (8.0%) | 0.39 |
Childhood | N = 351 | 109 (89.3%) | 242 (92.0%) | |
Symptoms | No | 101 (82.8%) | 213 (81.0%) | 0.67 |
yes | 21 (17.2%) | 50 (19.0%) | ||
ECG at diagnosis | FC median [Q1; Q3] | 70 [53.0; 100.0] | 50 [45; 65] | <0.0001 |
QRS Median [Q1; Q3] | 70 [60.0; 80.0] | 69 [60.0; 80.0] | 0.31 | |
QTc Median [Q1; Q3] | 409 [390; 425] | 412 [400; 433] | 0.20 |
. | Incomplete (N = 122) . | Complete (N = 263) . | P-value . | |
---|---|---|---|---|
Sex | Women | 57 (46.7%) | 136 (51.7%) | 0.36 |
Men | 65 (53.3%) | 127 (48.3%) | ||
Age at diagnosis | Min–max | [0.0; 17.0] | [0.0; 18.0] | 0.0109 |
Mean ± SD | 3.6 ± 3.9 | 4.7 ± 4.7 | ||
Median [Q1; Q3] | 2.0 [1.0; 6.0] | 3.0 [0.0; 7.0] | ||
Congenital | N = 34 | 13 (10.7%) | 21 (8.0%) | 0.39 |
Childhood | N = 351 | 109 (89.3%) | 242 (92.0%) | |
Symptoms | No | 101 (82.8%) | 213 (81.0%) | 0.67 |
yes | 21 (17.2%) | 50 (19.0%) | ||
ECG at diagnosis | FC median [Q1; Q3] | 70 [53.0; 100.0] | 50 [45; 65] | <0.0001 |
QRS Median [Q1; Q3] | 70 [60.0; 80.0] | 69 [60.0; 80.0] | 0.31 | |
QTc Median [Q1; Q3] | 409 [390; 425] | 412 [400; 433] | 0.20 |
Statistically significant P-value < 0.05 are marked in bold.
Clinical characteristics at the time of diagnosis of incomplete and complete AVB
. | Incomplete (N = 122) . | Complete (N = 263) . | P-value . | |
---|---|---|---|---|
Sex | Women | 57 (46.7%) | 136 (51.7%) | 0.36 |
Men | 65 (53.3%) | 127 (48.3%) | ||
Age at diagnosis | Min–max | [0.0; 17.0] | [0.0; 18.0] | 0.0109 |
Mean ± SD | 3.6 ± 3.9 | 4.7 ± 4.7 | ||
Median [Q1; Q3] | 2.0 [1.0; 6.0] | 3.0 [0.0; 7.0] | ||
Congenital | N = 34 | 13 (10.7%) | 21 (8.0%) | 0.39 |
Childhood | N = 351 | 109 (89.3%) | 242 (92.0%) | |
Symptoms | No | 101 (82.8%) | 213 (81.0%) | 0.67 |
yes | 21 (17.2%) | 50 (19.0%) | ||
ECG at diagnosis | FC median [Q1; Q3] | 70 [53.0; 100.0] | 50 [45; 65] | <0.0001 |
QRS Median [Q1; Q3] | 70 [60.0; 80.0] | 69 [60.0; 80.0] | 0.31 | |
QTc Median [Q1; Q3] | 409 [390; 425] | 412 [400; 433] | 0.20 |
. | Incomplete (N = 122) . | Complete (N = 263) . | P-value . | |
---|---|---|---|---|
Sex | Women | 57 (46.7%) | 136 (51.7%) | 0.36 |
Men | 65 (53.3%) | 127 (48.3%) | ||
Age at diagnosis | Min–max | [0.0; 17.0] | [0.0; 18.0] | 0.0109 |
Mean ± SD | 3.6 ± 3.9 | 4.7 ± 4.7 | ||
Median [Q1; Q3] | 2.0 [1.0; 6.0] | 3.0 [0.0; 7.0] | ||
Congenital | N = 34 | 13 (10.7%) | 21 (8.0%) | 0.39 |
Childhood | N = 351 | 109 (89.3%) | 242 (92.0%) | |
Symptoms | No | 101 (82.8%) | 213 (81.0%) | 0.67 |
yes | 21 (17.2%) | 50 (19.0%) | ||
ECG at diagnosis | FC median [Q1; Q3] | 70 [53.0; 100.0] | 50 [45; 65] | <0.0001 |
QRS Median [Q1; Q3] | 70 [60.0; 80.0] | 69 [60.0; 80.0] | 0.31 | |
QTc Median [Q1; Q3] | 409 [390; 425] | 412 [400; 433] | 0.20 |
Statistically significant P-value < 0.05 are marked in bold.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.